EDNRA and neoplasm: Since it is conceivable that antiapoptotic factors may contribute to resistance to antitumoral therapy, the observed chemotherapy resistance in ET receptor overexpressing tumours may be attributed to the autocrine influence of ET-1 acting via ETAR.